New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
08:11 EDTAMPEAmpio closes enrollment in OptimEyes study for presentation to FDA
Ampio Pharmaceuticals has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema - oral treatment with Optina. The present enrollment of over 355 patients provides an adequate power of 88%, which the company believes is more than sufficient for statistical evaluation. By reducing the patient sample size, the company expects data by Q4.
News For AMPE From The Last 14 Days
Check below for free stories on AMPE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2014
12:45 EDTAMPEAmpio knee drug 'no better than saline,' says TheStreet's Feuerstein
Subscribe for More Information
September 2, 2014
08:03 EDTAMPEAmpio provided update of Phase III multicenter study of Ampion
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use